C2718191||Cyclin D2
C0030956||peptide
C1516337||cell cycle phases
C0600388||ERK1/2
C0007465||cause the death
C1512505||breast cancer cells
C0597304||Protein degradation
C1752727||proteasome
C0178719||intracellular
C0030956||peptides
C0030956||Pep5
C0030956||peptide
C2718191||Cyclin D2
C0007587||cell death
C0085983||tumor cell lines
C0034693||rat
C0017636||C6 glioblastoma tumors
C1515655||in vivo
C3898556||human MDA-MB-231
C1512505||breast cancer cells
C0220825||evaluate
C1708951||mechanism of cell death
C0030956||pep5
C1516337||phases of the cell cycle
C0079367||Fluorescently labeled
C0030956||pep5
C0242842||real time confocal microscopy
C3898556||MDA-MB-231
C1512505||cells
C0392752||localized
C0007610||nucleus
C0010834||cytoplasm
C0030956||Pep5
C0007587||cell death
C3898556||MDA-MB-231
C1512505||cell population
C1517341||G1/S transition
C0007634||cells
C0030956||Pep5
C0600388||extracellular signal-regulated kinase
C0600388||ERK1/2
C0031715||phosphorylation
C3898556||MDA-MB-231
C1512505||cells
C1517341||G1/S
C0008551||Affinity chromatography
C0037813||mass spectrometry
C1314856||CLIC1
C0071277||Plectin
C0033684||proteins
C0030956||pep5
C3898556||MDA-MB-231
C1512505||cells
C0600388||ERK1/2
C0031715||phosphorylation
C0010853||cytoskeleton
C3898556||MDA-MB-231
C1512505||cells
C0887904||stress fibers
C0030956||pep5
C0087111||treatments
C0030956||pep5
C0087111||treating
C0006826||cancers
C1512505||breast cancer cells
C0030956||Pep5
C0178719||intracellular
C0030956||peptide
C0597304||degradation of Cyclin D2
C1523807||ubiquitin-proteasome system
C0007587||cell death
C3898556||MDA-MB-231
C1512505||breast cancer cells
C2718191||Cyclin D2
C1517341||G1/S
C0007634||arrested cells
C0007634||cells
C0030956||pep5
C0178719||intracellular
C0033684||proteins
C0010853||cytoskeleton
C0208355||proteasome components
C0162638||cellular apoptosis
C0030956||pep5
C0178719||intracellular
C0030956||peptide
C0087111||treating
C0027651||tumors
C1171362||expression
C2718191||Cyclin D2
C0596290||cell proliferation